IndraLab
Statements
reach
"This NDRG3-dependent tumor-promoting activity of USP9X in KRAS-driven pancreatic tumorigenesis might be specifically inhibited by targeting the KRAS-NDRG3-USP9X axis.NDRG3 protein was predicted to assume flexible structures at the N- and C-terminal regions, unlike the central NDR domain with an ordered structure consisting of α-helices and β-sheets (https://xtalpred.godziklab.org/XtalPred-cgi/xtal.pl) ."
reach
"Moreover, knockdown of USP9X or TTK inhibited cell proliferation, migration and tumorigenesis, and the immunohistochemical analysis of clinical NSCLC samples showed that the protein expression levels of USP9X and TTK were significantly elevated and positively correlated in tumor tissues.Conclusions: In summary, our data demonstrated that the USP9X-TTK axis may play a critical role in NSCLC, and could be considered as a potential therapeutic target."